○Takaaki Sasaki¹, Takuomi Hosaka¹, Ryota Shizu¹, Takamitsu Sasaki¹, Kouichi Yoshinari¹ (1. Grad. Sch. Pharm. Sci., Univ. of Shizuoka)

○Sanae Katsuyama¹, Takuomi Hosaka¹, Ryota Shizu¹, Takamitsu Sasaki¹, Kouichi Yoshinari¹ (1. Grad. Sch. Pharm. Sci., Univ. of Shizuoka)

○Taichi Matsumoto¹, Shiro Jimi², Kazuhiko Ono¹, Masahiko Kimura¹, Keisuke Migita¹, Shuuji Hara¹ (1. Pharm. Sci., Fukuoka Univ., 2. Sch. Med., Fukuoka Univ.)

○Yusaku Matsushita¹, Yoichi Sunagawa^1,2,3, Mizuki Unno¹, Masafumi Funamoto^1,2, Kana Shimizu^1,2, Satoshi Shimizu^1,2, Nurmila Sari¹, Yasufumi Katanasaka^1,2,3, Yusuke Miyazaki^1,2,3, Hiromichi Wada², Koji Hasegawa^1,2, Tatsuya Morimoto^1,2,3 (1. Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, 2. Division of Translational Research, Clinical Research Institute, Kyoto Medical Center, National Hospital Organization, 3. Shizuoka General Hospital)

○Miyu Motoyama¹, Takafumi Hara¹, Saki Uraka¹, Kimiko Nakajima², Emi Yoshigai¹, Teruhisa Takagishi¹, Taro Irie³, Shigetoshi Sano², Toshiyuki Fukada¹ (1. Facluty. Pharmceut. Sci., Tokushima Bunri Univ., 2. Sch. Med., Kochi Univ., 3. Sch. Dent., Iwate Med Univ.)

○Hiroaki Kito¹, Susumu Ohya¹ (1. Grad. Sch. Med. Sci., Nagoya City Univ.)

○Haruka Ohori¹, Shingo Matsuyama¹, Masato Toda², Yukihiko Osaki², Yoichiro Isohama¹ (1. Facul. of Pharm. Sci., Tokyo Univ. of Sci., 2. Kobayashi Pharm Co., Ltd. Central Research Lab.)

○Kazuki Yoshida¹, Yuu Ishida¹, Masaaki Ito¹, Isao Matsuoka¹ (1. Takasaki univ. of health and welfare)